Pharma Journalist -

NKGen Biotech, Inc., a biotechnology company harnessing the power of the body’s immune system through the development of natural killer (NK) cell therapies, announced a collaboration…
Read More...

BeiGene announced that the European Commission (EC) has granted marketing authorization of BRUKINSA (zanubrutinib) for the treatment of adult patients with relapsed/refractory (R/R)…
Read More...

ReiThera, a biotech company dedicated to the development of new technologies, GMP production and the clinical translation of genetic vaccines and products for advanced therapies,…
Read More...

Sinovac Biotech Ltd. announced that it received prequalification from the World Health Organization (WHO) for its live attenuated varicella vaccine on November 3, 2022. This marks the…
Read More...

Evotec SE announced that the acquisition of Central Glass Germany GmbH from the Japanese chemical manufacturing company Central Glass Co. Ltd., signed in August 2022, has been…
Read More...

Exelixis, Inc. and Catalent, Inc. announced a new license agreement under which Catalent’s Redwood Bioscience subsidiary will grant Exelixis an exclusive license to three target…
Read More...

AstraZeneca's COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), has been granted full Marketing Authorisation (MA) in the European Union (EU). Vaxzevria was originally granted a conditional…
Read More...

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy (tenofovir alafenamide) 25 mg…
Read More...

Emalex Biosciences announced the closing of an upsized and oversubscribed $250 million Series D funding round that will fund a Phase 3 clinical trial and potential commercialization of…
Read More...

Ascletis Pharma Inc. announces that the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease (3CLpro) for…
Read More...